The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients - PubMed (original) (raw)
The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients
Farzaneh Montazerifar et al. Cardiol Res. 2016 Dec.
Abstract
Background: Metabolic syndrome (MetS) is a worldwide health problem, which is growing in Iranian adults. MetS is associated with risk of type 2 diabetes and coronary artery disease (CAD). In this study, we aimed to investigate the prevalence of MetS and its individual components in CAD patients.
Methods: This cross-sectional study was performed on 200 CAD patients who had undergone elective coronary angiography at the cardiology department. Anthropometric indices including waist circumference (WC) and body mass index were measured. Blood samples were obtained to determine glucose and lipid profile. MetS components were defined according to the modified Adult Treatment Panel III (ATP III) criteria.
Results: The prevalence of MetS among patients was 49.5% (women: 55.9%; men: 40.2%; P < 0.05). The prevalence increased with age. The low high-density lipoprotein-cholesterol (low HDL-C) (84.8%), high fasting blood glucose (high FBG) (77.8%) and high WC (75.8%) were the most prevalent risk factors in CAD patients with MetS.
Conclusions: Recent data indicate that the dyslipidemia, hyperglycemia and abdominal obesity are crucial predictors of MetS in CAD patients. Further prospective studies are recommended for more clarification.
Keywords: Coronary artery disease; Metabolic syndrome; Prevalence.
Similar articles
- The most appropriate cut-off point of anthropometric indices in predicting the incidence of metabolic syndrome and its components.
Farhangiyan Z, Latifi SM, Rashidi H, Shahbazian H. Farhangiyan Z, et al. Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2739-2745. doi: 10.1016/j.dsx.2019.07.009. Epub 2019 Jul 16. Diabetes Metab Syndr. 2019. PMID: 31405702 - Comparison of Three Adiposity Indexes and Cutoff Values to Predict Metabolic Syndrome Among University Students.
Correa-Bautista JE, González-Ruíz K, Vivas A, Triana-Reina HR, Martínez-Torres J, Prieto-Benavides DH, Carrillo HA, Ramos-Sepúlveda JA, Afanador-Rodríguez MI, Villa-González E, García-Hermoso A, Ramírez-Vélez R. Correa-Bautista JE, et al. Metab Syndr Relat Disord. 2017 Sep;15(7):363-370. doi: 10.1089/met.2017.0016. Epub 2017 Jun 1. Metab Syndr Relat Disord. 2017. PMID: 28570830 - The value of wrist circumference for predicting the presence of coronary artery disease and metabolic syndrome.
Hajsadeghi S, Firouzi A, Bahadoran P, Hassanzadeh M. Hajsadeghi S, et al. Indian Heart J. 2016 Dec;68 Suppl 3(Suppl 3):S5-S9. doi: 10.1016/j.ihj.2016.10.011. Epub 2016 Nov 5. Indian Heart J. 2016. PMID: 28038723 Free PMC article. - The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
Garg PR, Kabita S, Sinha E, Kalla L, Kaur L, Saraswathy KN. Garg PR, et al. Ann Hum Biol. 2013 Jan;40(1):111-5. doi: 10.3109/03014460.2012.744094. Epub 2012 Nov 30. Ann Hum Biol. 2013. PMID: 23198906 - Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Hosseini-Esfahani F, Bahadoran Z, Moslehi N, Asghari G, Yuzbashian E, Hosseinpour-Niazi S, Mirmiran P, Azizi F. Hosseini-Esfahani F, et al. Int J Endocrinol Metab. 2018 Oct 21;16(4 Suppl):e84771. doi: 10.5812/ijem.84771. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584438 Free PMC article. Review.
Cited by
- Metabolic syndrome and its associated factors among adults with cardiac diseases: A cross-sectional comparative group study.
Abera A, Shifeta M, Tesfaye S, Addisu B, Hirigo AT. Abera A, et al. JRSM Cardiovasc Dis. 2024 Aug 16;13:20480040241271789. doi: 10.1177/20480040241271789. eCollection 2024 Jan-Dec. JRSM Cardiovasc Dis. 2024. PMID: 39156492 Free PMC article. - 'Super Rehab': can we achieve coronary artery disease regression? A feasibility study protocol.
Graby J, Khavandi A, Gillison F, Smith T, Murphy D, Peacock O, McLeod H, Dastidar A, Antoniades C, Thompson D, Rodrigues JCL. Graby J, et al. BMJ Open. 2023 Dec 12;13(12):e080735. doi: 10.1136/bmjopen-2023-080735. BMJ Open. 2023. PMID: 38086597 Free PMC article. - Prevalence of metabolic syndrome and its association with atrial arrhythmias in patients with implanted permanent pacemaker for cardiac conduction abnormality.
Pai UM, Prabhu MA, Devasia DT, Rao DS, V R, Samanth J, Prabhu S, Mathias HL, V C. Pai UM, et al. Indian Heart J. 2023 Nov-Dec;75(6):462-464. doi: 10.1016/j.ihj.2023.10.006. Epub 2023 Oct 31. Indian Heart J. 2023. PMID: 37918562 Free PMC article. - Heart failure in patients with metabolic syndrome X.
Olatunbosun PP, El Hunjul GN, Patel A, Abbas RH, Mody S, Masalha A, Mehta S, Rizwan S, Pareek A, Jain S, Parambat SBC. Olatunbosun PP, et al. Discoveries (Craiova). 2023 Mar 3;11(1):e162. doi: 10.15190/d.2023.1. eCollection 2023 Jan-Mar. Discoveries (Craiova). 2023. PMID: 37496710 Free PMC article. Review. - New insights on the cardiovascular effects of IGF-1.
Macvanin M, Gluvic Z, Radovanovic J, Essack M, Gao X, Isenovic ER. Macvanin M, et al. Front Endocrinol (Lausanne). 2023 Feb 9;14:1142644. doi: 10.3389/fendo.2023.1142644. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843588 Free PMC article.
References
- Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B. et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(5):426–428. - PubMed
- Veghari GH, Sedaghat M, Banihashem S, Moharloei P, Angizeh A, Tazik E. et al. The Prevalence of Metabolic Syndrome in the North of Iran. An Epidemiologic Comparative Study. J Cardiovasc Disease Res. 2015;6(4):172–175. doi: 10.5530/jcdr.2015.4.1. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous